Sanofi Swoops In With $2.2 Billion Dynavax Acquisition on Christmas Eve
French pharma giant Sanofi announced a $2.2 billion deal to acquire Dynavax Technologies on Christmas Eve, sending shares soaring 38%. The deal expands Sanofi's adult vaccine franchise.